⚡ Asset Showdown Engine

ABBV vs JNJ

Head-to-head financial comparison for AbbVie Inc (ABBV) and Johnson & Johnson (JNJ).

🏆 Showdown Verdict

JNJ leads ABBV in 9 of 17 key financial metrics.

ABBV: 8 wins · JNJ: 9 wins
NEW YORK STOCK EXCHANGE, INC. · Biotechnology

ABBV

AbbVie Inc
$259.17
-0.96%
Market open
52-Week Range 89.2% of High
Low: $190.75 High: $267.47
💼
Profitability Winner Higher Operating & Net Margins
💰
Income Winner Higher Dividend Yield
🚀
Performance Winner Higher Historical Returns
NEW YORK STOCK EXCHANGE, INC. · Pharmaceuticals

JNJ

Johnson & Johnson
$259.17
-0.96%
Market open
52-Week Range 89.2% of High
Low: $190.75 High: $267.47
💼
Profitability Winner Higher Operating & Net Margins
💰
Income Winner Higher Dividend Yield
🚀
Performance Winner Higher Historical Returns
NEW YORK STOCK EXCHANGE, INC. · Pharmaceuticals

JNJ

Johnson & Johnson
$275.13
-0.11%
Market open
52-Week Range 94.5% of High
Low: $173.33 High: $281.07
🏷️
Valuation Winner Lower P/E & Multiples
🏛️
Scale Leader Larger Market Cap

Normalized % Return Comparison

Both assets indexed to 0.0% at the period start: ((Price_t - Price_0) / Price_0 * 100)

ABBV (AbbVie Inc) +27.04%
JNJ (Johnson & Johnson) +58.80%
JNJ leads by +31.76%
-13.4%+7.1%+27.5%+48.0%+68.4% Aug '25Nov '25Mar '26Jun '26Sep '26

Metric-by-Metric Breakdown

Direct quantitative comparison across valuation, margins, growth, and returns.

Financial Metric ABBV JNJ Showdown Advantage
Valuation & Multiples
Price Current market price per share / unit $259.17 $275.13
Market Capitalization Total aggregate market value of equity $462.49B $663.23B 👑 JNJ Larger
P/E Ratio (Trailing TTM) Price-to-earnings multiple (lower positive is cheaper) 70.24x 29.93x 👑 JNJ Cheaper
Forward P/E Price-to-projected next year earnings multiple 16.77x 20.74x 👑 ABBV Lower
PEG Ratio P/E divided by earnings growth rate (<1.0 considered undervalued) 6.59 3.39 👑 JNJ Lower
Price to Sales (P/S) Price relative to trailing revenue 6.88x 6.43x 👑 JNJ Lower
Price to Book (P/B) Stock price relative to book equity per share 261.01x 7.32x 👑 JNJ Lower
Profitability & Margins
Gross Profit Margin Gross revenue retained after cost of goods sold 72.79% 68.05% 👑 ABBV Higher
Operating Margin Operating income generated per dollar of revenue 26.20% 25.73% 👑 ABBV Higher
Net Profit Margin Net bottom-line profit generated per dollar of revenue 9.80% 21.48% 👑 JNJ Higher
Return on Equity (ROE) Net income earned per dollar of shareholders' equity 95.59% 25.74% 👑 ABBV Higher
Historical Performance & Growth
Revenue Growth (YoY) Year-over-year top-line revenue expansion rate +10.16% +6.60% 👑 ABBV Higher
1-Month % Return Historical total price return over the past 30 days +0.65% +8.07% 👑 JNJ Higher
6-Month % Return Historical total price return over the past 180 days +17.07% +15.31% 👑 ABBV Higher
1-Year % Return Historical total price return over the past 52 weeks +27.04% +58.80% 👑 JNJ Higher
5-Year % Return Historical total price return over 5 years +178.92% +80.72% 👑 ABBV Higher
Dividends & Risk
Dividend Yield Annual dividend distributions relative to current price 4.47% 3.12% 👑 ABBV Higher
Beta (Volatility vs S&P 500) Market sensitivity (1.0 = equal to market, <1.0 = lower volatility) 0.20 0.21
52-Week High & Low Extreme trading boundaries over trailing year $190.75 – $267.47 $173.33 – $281.07